Besides using early post-vaccination transcriptional analyses that occur at the cusp of the acquired immune response, others have developed functional assays, preferred by regulatory agencies, to examine potential CoP following vaccination with live tularemia vaccines including LVS. Here, CARD16 is linked to tularemia.